Pharma Market Access Insights - from Petauri Evidence
We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence.
Pharma Market Access Insights - from Petauri Evidence
Understanding the tipping point: When elective becomes selective in NHS surgery
Simon Parsons (Divisional Director of Surgery at Nottingham University Hospitals NHS Trust) joins Tom Clarke (Director, Mtech Access) to discuss how decisions, such as the postponement of non-urgent elective surgery, are made, the impact this has on patients and staff, and how the NHS might adapt to provide care for these patients.
In addition to his role as Divisional Director of Surgery at Nottingham University Hospitals NHS Trust, Simon Parsons is a Consultant Oesophago Gastric Surgeon. He works as part of the team of gastro-oesophageal surgeons in Nottingham carrying out a full range of cancer surgery on the stomach and oesophagus.
As Divisional Director, Simon is passionate about transformation of surgical services and believes technology plays a pivotal role in this transformation.
Simon is also a director of EIDO Healthcare Ltd., a company specialising in information for informed consent. EIDO has used technology to transform the way it delivers its services.
We were delighted to welcome Simon to the #WhispersWordsofWisdom series.
This podcast was first recorded as a video on 23rd October 2020.
Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insights/
Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence